Medicine News and Research

RSS

Exercise, nutrition and hormone optimization are key to improve men's health issues

Grant Mansell was 46 and frustrated with his 300 pound physique, ensuing back pain, rising cholesterol, dependency on blood pressure medicine but most of all not enjoying life with his wife and children.

8 Jan 2010

University of Washington and Aegis Living to promote wellness programs

Healthy aging is more than just a saying at Aegis Living, a national leader in assisted living and Memory Care communities. Now it's working with faculty at University of Washington School of Medicine to make strides in the advancement of healthy aging through collaborative efforts started in Aegis Living's new Living 4 Life® program.

8 Jan 2010

Murad launches new line of Anti-Aging Acne products for adults struggling with acne

Murad, Inc. has announced the launch of a new line of Anti-Aging Acne products for adults struggling with acne. The new Anti-Aging Acne line is the first comprehensive approach designed to restore a smooth, youthful complexion by addressing acne breakouts while diminishing the appearance of fine lines and wrinkles.

8 Jan 2010

LSUHSC receives $2.1 million grant for pneumonia research

Dr. Jay Kolls, Professor and Chairman of Genetics at the LSU Health Sciences Center New Orleans School of Medicine, has been awarded a $2.1 million grant over five years by the National Heart, Lung, and Blood Institute of the National Institutes of Health to further his work on a discovery that plays a critical role in the body's defense against pneumonia.

8 Jan 2010

Initiation of double blind placebo controlled multi-center trial of DAS181 announced

NexBio, Inc. announced today the initiation of a double blind placebo controlled multi-center trial in the U.S. and Mexico of DAS181 (Fludase®) for the treatment of laboratory confirmed influenza infection.

8 Jan 2010

Pfizer and Debiopharm Group enter into co-development agreement to conduct Phase 3 trial of tremelimumab

Pfizer Inc. (Pfizer) and Debiopharm Group™ (Debiopharm) announced today that they have entered into a co-development agreement to conduct a Phase 3 trial of tremelimumab (CP675,206), a fully human anti-CTLA4 monoclonal antibody for the treatment of patients with unresectable, Stage IV melanoma.

8 Jan 2010

Kyowa Hakko Kirin receives exclusive rights to develop and commercialize bardoxolone methyl

Reata Pharmaceuticals, Inc. (Reata) and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin) announced today that they have entered into a licensing agreement that provides Kyowa Hakko Kirin with the exclusive rights to develop and commercialize Reata’s lead compound, bardoxolone methyl (bardoxolone), in Japan and other selected Asian markets.

8 Jan 2010

Springer signs agreement with ISOBM to co-publish the journal Tumor Biology

Springer, a leading publisher in the fields of science, technology and medicine, has signed an agreement with the International Society of Oncology and BioMarkers (ISOBM) to co-publish the journal Tumor Biology starting in January 2010.

8 Jan 2010

HHS releases nation’s first comprehensive strategy to address existing and emerging health threats

HHS Secretary Kathleen Sebelius today released The National Health Security Strategy, the nation’s first comprehensive strategy focused on protecting people’s health during a large-scale emergency. The strategy sets priorities for government and non-government activities over the next four years.

8 Jan 2010

UCLA: Metformin can be used to treat patients with diabetes and advanced heart failure

A new study has shown that metformin, a drug often used in the treatment of diabetes mellitus, is safe for use in treating patients who have both diabetes and advanced heart failure.

7 Jan 2010

Epigenetic diagnosis and therapies, a new strategy for treating cancer

A tumor's genetic profile is often useful when diagnosing and deciding on treatment for certain cancers, but inexplicably, genetically similar leukemias in different patients do not always respond well to the same therapy.

7 Jan 2010

CRF awards $1.75 million in 11 new grants to researchers to find a cure for cystinosis

The Cystinosis Research Foundation of Irvine, Calif., announced it awarded $1.75 million in 11 new grants to researchers in the United States, Canada, Belgium and Italy who are working to find a cure for cystinosis, a rare, deadly metabolic and genetic disease that afflicts about 500 children and young adults in the U.S. and 2,000 worldwide.

7 Jan 2010

China Medicine enters into Stock Subscription Agreement with OEP

China Medicine Corporation ("China Medicine" or "the Company"), primarily a leading distributor and a developer of Western pharmaceuticals, traditional Chinese medicines ("TCM"), and other nutriceuticals today announced that it has entered into a Stock Subscription Agreement for an equity private placement (the "Subscription Agreement") with One Equity Partners ("OEP"), the global private equity investment arm of JPMorgan Chase & Co.

7 Jan 2010

Carolinas MED-1 to house a clinic for residents to get H1N1 Flu shots

Carolinas MED-1 - the first mobile hospital of its kind in the world - will be serving the people of Charlotte and Mecklenburg County when it is deployed this Saturday for an H1N1 vaccine clinic.

7 Jan 2010

New genetic findings may lead to better interventional therapies for obsessive compulsive disorders

A collaboration between the University of Massachusetts Medical School, the Cummings School of Veterinary Medicine at Tufts University and the Broad Institute at the Massachusetts Institute of Technology has identified a genetic locus on canine chromosome 7 which coincides with an increased risk of obsessive compulsive disorder (OCD) susceptibility.

7 Jan 2010

Tel Aviv University finds Mozart's music induces weight gain in premature babies

The music they listen to doesn't have any lyrics that tell them to grow, but new research from Tel Aviv University finds that premature babies who are exposed to music by 18th-century composer Wolfgang Amadeus Mozart gain weight faster -- and therefore become stronger -- than those who don't.

7 Jan 2010

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.

7 Jan 2010

Biggest Loser implements MedGem indirect calorimeter to assess metabolic changes in program contestants

Microlife Medical Home Solutions, Inc. (MiMHS) announces The Biggest Loser medical staff will implement the MedGem indirect calorimeter to assess metabolic changes in program contestants. The MedGem handheld indirect calorimeter is an FDA-cleared, Class II, medical device that assesses metabolic rate by measuring a patient’s resting oxygen consumption.

7 Jan 2010

Rx Locker device to secure prescription medications

Due to the rising statistics about teens and prescription drug abuse, Dr. Drew Pinsky, host of Celebrity Rehab and Loveline, recently debuted the Rx Locker, a device designed to secure prescription medications within the home to restrict unauthorized access and prevent abuse.

7 Jan 2010

Apoteket and Medco Health Solutions develop centralized prescription safety program

Apoteket, Sweden's largest pharmacy chain, and Medco Health Solutions, Inc. today announced that it has developed one of the first national centralized drug utilization review (DUR) programs outside of the United States to improve prescription safety by reducing adverse drug events and thereby reducing the risk of costly hospitalizations.

7 Jan 2010

Medicine News and Research

Exercise, nutrition and hormone optimization are key to improve men's health issues

University of Washington and Aegis Living to promote wellness programs

Murad launches new line of Anti-Aging Acne products for adults struggling with acne

LSUHSC receives $2.1 million grant for pneumonia research

Initiation of double blind placebo controlled multi-center trial of DAS181 announced

Pfizer and Debiopharm Group enter into co-development agreement to conduct Phase 3 trial of tremelimumab

Kyowa Hakko Kirin receives exclusive rights to develop and commercialize bardoxolone methyl

Springer signs agreement with ISOBM to co-publish the journal Tumor Biology

HHS releases nation’s first comprehensive strategy to address existing and emerging health threats

UCLA: Metformin can be used to treat patients with diabetes and advanced heart failure

Epigenetic diagnosis and therapies, a new strategy for treating cancer

CRF awards $1.75 million in 11 new grants to researchers to find a cure for cystinosis

China Medicine enters into Stock Subscription Agreement with OEP

Carolinas MED-1 to house a clinic for residents to get H1N1 Flu shots

New genetic findings may lead to better interventional therapies for obsessive compulsive disorders

Tel Aviv University finds Mozart's music induces weight gain in premature babies

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

Biggest Loser implements MedGem indirect calorimeter to assess metabolic changes in program contestants

Rx Locker device to secure prescription medications

Apoteket and Medco Health Solutions develop centralized prescription safety program

Everything there is to know about biosimilars eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News